PATENT CLAIM ANALYSIS

Application Number: 15893771
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-06
Patent Classification: ["514", "415000"]

Abstract:
This invention relates to crystalline forms of (R)-1-(1-(methylsulfonyl)propan-2-yl)-4-(trifluoromethyl)indoline-5-carbonitrile, a modulator of the androgen receptor, and methods for the use in treatment.

Claim (Index 5):
The crystalline form of  claim 1  that is further characterized by an  13 C SSNMR (solid state nuclear magnetic resonance) spectrum comprising isotropic chemical shifts at 140.1\u00b10.2, 136.9\u00b10.2, 134.9\u00b10.2, 130.4\u00b10.2, 128.5\u00b10.2, 126.6\u00b10.2, 126.0\u00b10.2, 125.7\u00b10.2, 124.8\u00b10.2, 121.9\u00b10.2, 120.9\u00b10.2, 119.7\u00b10.2, 118.6\u00b10.2, 115.5\u00b10.2, 115.1\u00b10.2, 103.6\u00b10.2, 100.3\u00b10.2, 98.9\u00b10.2, 58.1\u00b10.2, 55.7\u00b10.2, 54.7\u00b10.2, 51.1\u00b10.2, 50.4\u00b10.2, 44.7\u00b10.2, 43.6\u00b10.2, 40.7\u00b10.2, 23.5\u00b10.2 and 20.7\u00b10.2 ppm, wherein the  13 C SSNMR spectrum is obtained on a spectrometer operating at a frequency of 125.73 MHz for  13 C observation using a cross-polarization pulse sequence with a Bruker 4-mm triple resonance magic-angle spinning probe at a rotor frequency of 8 kHz.

Metadata:
- Claim Count in Document: 34.0
- Percentile: 88.0
- Lexical Diversity: 1.3
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15111068', '13389525', '13941911', '15358458', '14549034']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7293963613738351
- 35 USC 102 Novelty (BERT): 0.5664939250022533
- Combined Prediction Score: 0.7131061177366769
- Mean Citation Score: 238.344134
- Max Citation Score: 441.6624
- Similarity Product: 392.92571194467536

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test